Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

Journal of the American College of Cardiology

Volumn 37, Issue 7, 2001, Pages 1820-1826

  Hayashi, Masaru ^a   Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Maeda, Keiko ^a   Mabuchi, Naoko ^a   Tsutsui, Takashi ^a   Horie, Hajime ^a   Ohnishi, Masato ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; DIURETIC AGENT; ENALAPRIL; ENDOTHELIN 1; GLYCERYL TRINITRATE; NEUROHORMONE; NITRATE;

ACUTE HEART INFARCTION; ADULT; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ATRIAL NATRIURETIC FACTOR; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 0035369120     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01233-5     Document Type: Article

References (31)

1. Variables predictive of survival in patients with coronary artery disease: Selection by univariate and multivariate analysis from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations
2. Intravenous nitroglycerin therapy to limit myocardial infarction size, expansion and complications: Effect of timing, dosage and infarct location
3. Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction
4. Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure
5. Atrial natriuretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal, and hemodynamic responses peptide infusion
6. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor
7. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors
8. Cellular mechanism of natriuretic peptide-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells
9. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes
10. Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction
11. Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts
12. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
13. Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure
14. Attenuation of reflex forearm vasoconstriction by alpha human atrial natriuretic peptide in men
15. Disorders of aldosterone biosynthesis and action
16. Chronic mineralocorticoid excess and cardiovascular remodeling
17. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
18. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
19. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin angiotensin aldosterone system
20. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
21. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction
22. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
23. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone administration
24. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
25. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression
26. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
27. Effects of endothelins on collagen turnover in cardiac fibroblasts
28. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rat with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
29. Transcardiac extraction of circulating endothelin-1 across the failing heart
30. Survival after an experimental myocardial infarction: Beneficial effect of long-term therapy with captopril
31. Which patient benefits from early angiotensin-converting enzyme inhibitor after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril And Thrombolysis Study (CATS)